EXEL

Exelixis, Inc.

22.06 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Exelixis, Inc. stock is up 5.1% since 30 days ago. The next earnings date is Jul 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 56% of the previous 24 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 May 18:57 16 Aug, 2024 22.00 CALL 162 1048
15 May 15:12 21 Jun, 2024 19.00 PUT 1569 35
15 May 15:12 21 Jun, 2024 19.00 PUT 434 35
15 May 18:28 21 Jun, 2024 19.00 PUT 573 35
15 May 18:32 21 Jun, 2024 21.00 CALL 440 2321
16 May 16:33 21 Jun, 2024 22.00 CALL 500 1663
17 May 14:05 19 Jul, 2024 23.00 CALL 935 0
31 May 17:30 15 Nov, 2024 18.00 CALL 150 0
31 May 17:31 15 Nov, 2024 18.00 CALL 150 0
06 Jun 17:37 21 Jun, 2024 22.00 PUT 369 1480

About Exelixis, Inc.

Exelixis, Inc. focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. Its products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma.